Loading clinical trials...
Loading clinical trials...
Anti-vascular endothelial growth factor (VEGF) therapy is currently the mainstay of treatment for diabetic macular edema (DME). One of the main obstacles of anti-VEGF therapy is the need of repeated i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cairo University
NCT07296952 · Diabetic Retinopathy (DR)
NCT07354477 · Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG), and more
NCT07351786 · Diabetes (DM), Retinopathy, Diabetic, and more
NCT03161652 · Diabetic Macular Edema, Diabetic Retinopathy
NCT03713268 · Macular Holes, Epiretinal Membrane, and more
Faculty of Medicine, Cairo University
Cairo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions